Efficacy and safety of subcutaneous vivaglobin® replacement therapy in previously untreated patients with primary immunodeficiency: A prospective, multicenter study

1. Borte, M.
2. Quinti, I.
3. Soresina, A.
4. Fernández-Cruz, E.
5. Ritchie, B.
6. Schmidt, D.S.
7. McCusker, C.